01 1Nippon Protein Co Ltd
01 1L-CYSTEINE HYDROCHLORIDE MONOHYDRATE
01 1Japan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-08-14
Pay. Date : 2018-07-02
DMF Number : 21364
Submission : 2008-02-26
Status : Active
Type : II
20
Nippon Protein Co Ltd, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is L-CYSTEINE HYDROCHLORIDE MONOHYDRATE, with a corresponding US DMF Number 21364.
Remarkably, this DMF maintains an Active status since its submission on February 26, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 14, 2018, and payment made on July 02, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
